NFKB1 and atherosclerosis: (2) As previously demonstrated, IL-1β and related signaling pathways promote atherosclerosis; therefore, blocking IL-1β could ameliorate atherogenesis [18] and attenuate the NF-κB signaling used by GBE to reduce myocardial inflammation.